Obesity-associated inflammation and cancer: molecular mechanisms, evidence gaps, and therapeutic opportunities.
- 1The Second Affiliated Hospital of Dalian Medical University, Dalian, China.
- 2School of Public Health, Dalian Medical University, Dalian, China.
Abstract
Obesity, recognized as a significant global public health issue, has garnered widespread attention. The chronic systemic inflammatory state characteristic of obesity may act as a key pathophysiological factor in the development of obesity-related cancers. Based on a structured literature search of peer-reviewed databases, this review summarizes the features of the inflammatory microenvironment within adipose tissue in obesity, encompassing adipocyte hypertrophy and hyperplasia, hypoxia, and endoplasmic reticulum stress; activation of pro-inflammatory cytokines and signaling pathways; and the polarization of immune cells towards a pro-inflammatory phenotype. We emphasize the molecular mechanisms that link inflammation to carcinogenesis and explore targeted therapeutic strategies against inflammation, such as cytokine and receptor blockade, immune cell reprogramming, natural anti-inflammatory agents, and nanoparticle drug delivery systems. This review highlights the mechanistic link between obesity, inflammation, and cancer, providing insights for the development of precise preventive and therapeutic approaches for obesity-associated inflammation and tumorigenesis.
Related
- Microbiota-Associated Metabolites as Immunometabolic Regulators of Glomerular Inflammation: Disease-Specific Mechanisms and Therapeutic Opportunities.
- Chronic Inflammation, Fibrotic Remodeling, and Regenerative Failure in Duchenne Muscular Dystrophy: Mechanisms and Therapeutic Opportunities
- Autophagy and Inflammation in Cardiothoracic Surgery: The Mechanisms of Perioperative Lung Injury and Therapeutic Opportunities.
- Glioblastoma stem cell–immune microenvironment crosstalk: molecular mechanisms and therapeutic opportunities
- Germinal center and extrafollicular dysregulation in systemic lupus erythematosus: Mechanisms and therapeutic opportunities
BibTeX
@article{meng2026obesityassociated,
title = {{Obesity-associated inflammation and cancer: molecular mechanisms, evidence gaps, and therapeutic opportunities.}},
author = {Jiayi Meng and Xu Bao},
journal = {Frontiers in immunology},
year = {2026},
month = sep,
doi = {10.3389/fimmu.2026.1961059},
url = {https://europepmc.org/article/MED/42835412},
note = {CC BY},
}
RIS
TY - JOUR
TI - Obesity-associated inflammation and cancer: molecular mechanisms, evidence gaps, and therapeutic opportunities.
AU - Jiayi Meng
AU - Xu Bao
PY - 2026
DA - 2026/09/21
JO - Frontiers in immunology
DO - 10.3389/fimmu.2026.1961059
UR - https://europepmc.org/article/MED/42835412
AB - Obesity, recognized as a significant global public health issue, has garnered widespread attention. The chronic systemic inflammatory state characteristic of obesity may act as a key pathophysiological factor in the development of obesity-related cancers. Based on a structured literature search of peer-reviewed databases, this review summarizes the features of the inflammatory microenvironment within adipose tissue in obesity, encompassing adipocyte hypertrophy and hyperplasia, hypoxia, and endoplasmic reticulum stress; activation of pro-inflammatory cytokines and signaling pathways; and the polarization of immune cells towards a pro-inflammatory phenotype. We emphasize the molecular mechanisms that link inflammation to carcinogenesis and explore targeted therapeutic strategies against inflammation, such as cytokine and receptor blockade, immune cell reprogramming, natural anti-inflammatory agents, and nanoparticle drug delivery systems. This review highlights the mechanistic link between obesity, inflammation, and cancer, providing insights for the development of precise preventive and therapeutic approaches for obesity-associated inflammation and tumorigenesis.
SN - 1664-3224
ER -